TFP
MRNA icon

Tilia Fiduciary Partners’s Moderna MRNA Stock Holding History

Tilia Fiduciary Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-109
Closed -$13.2K – 327
2023
Q2 		$13.2K Sell
109
-4
-4% -$534 0.01% 352
2023
Q1 		$17.4K Buy
113
+109
+2,725% +$18K 0.02% 317
2022
Q4 		$718 Hold
4
– – ﹤0.01% 480
2022
Q3 		$0 Hold
4
– – ﹤0.01% 525
2022
Q2 		$1K Hold
4
– – ﹤0.01% 513
2022
Q1 		$1K Hold
4
– – ﹤0.01% 520
2021
Q4 		$1K Buy
+4
New +$1.17K ﹤0.01% 540

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Tilia Fiduciary Partners's MRNA Position: Q3 2023 in Review

Tilia Fiduciary Partners sold out of Moderna (MRNA) in Q3 2023, closing a stake of 109 shares — an estimated $13.2K sold.

Tilia Fiduciary Partners first reported a position in MRNA in Q4 2021 and held it in 7 quarters. The position peaked at $17.4K in Q1 2023. 890 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Tilia Fiduciary Partners reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Tilia Fiduciary Partners sold 109 Moderna shares in Q3 2023, an estimated $13.2K.
  • Tilia Fiduciary Partners first reported a position in Moderna in Q4 2021 and held it in 7 quarters.
  • Tilia Fiduciary Partners's Moderna position peaked at $17.4K in Q1 2023.
  • 890 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Tilia Fiduciary Partners's 13F filing for Q3 2023, filed 10 Oct 2023.